Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The Government is keen for academies and schools performing well to agree to formally sponsor low performing schools. Currently, the Office of the Schools Commissioner (OSC) are unlikely to approve a sponsor application from a collaboration of schools without a lead school as sponsor because they want to see a clear line of accountability.
A recent survey conducted by Ipsos Mori on behalf of Browne Jacobson LLP shows whilst there is appetite amongst schools to embrace collaborative approaches more than half of all recently converted academies feel they lack the necessary knowledge and could benefit from additional guidance and support before agreeing to sponsor.
The number school sponsors could be increased if the OSC were willing to approve Teaching School Alliances and other mature school-led formal partnerships as sponsors. Such a solution would mitigate againts the risk of adverse impact on the supporting school, utilise existing governance arrangements to provide clear accountability whilst providing a local solution that could be popular for low performing schools.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up